The European preeclampsia market is set for robust expansion over the 2025–2035 decade, underpinned by rising maternal-health screening, growing adoption of biomarker diagnostics, and increasing commitment to early detection. As healthcare systems across the region strive to reduce pregnancy-related complications, preeclampsia diagnostics are emerging as a central...